We are live on ! Find out more

49 hedge funds and large institutions have $10M invested in cbdMD in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 16 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

223% more call options, than puts

Call options by funds: $271K | Put options by funds: $84K

0% less ownership

Funds ownership: 0.05%0.05% (-0%)

6% less funds holding

Funds holding: 5249 (-3)

10% less capital invested

Capital invested by funds: $11.1M → $10M (-$1.13M)

25% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 16

27% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 11

Holders
49
Holders Change
-3
Holders Change %
-5.77%
% of All Funds
0.77%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
12
Reduced
16
Closed
11
Calls
$271K
Puts
$84K
Net Calls
+$187K
Net Calls Change
-$123K

YCBD Hedge Fund Activity: Q1 2022 in Review

49 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in cbdMD (YCBD) for Q1 2022, worth a combined $10M — down 10% from $11.1M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of YCBD and 8 opened new positions — a net loss of 3 holders — while 16 trimmed existing stakes and 12 added.

The largest buyer was Ameriprise, adding an estimated $230K. The largest seller was Bridgeway Capital Management, cutting an estimated $299K.

  • 49 institutional investors held cbdMD (YCBD) as of Q1 2022, down from 52 in Q4 2021.
  • Funds reported $10M of cbdMD stock for Q1 2022, down 10% quarter-over-quarter.
  • 8 funds opened new cbdMD positions in Q1 2022 and 11 closed out, a net change of -3 holders.
  • The largest cbdMD buyer in Q1 2022 was Ameriprise, an estimated $230K added.
  • The largest cbdMD seller in Q1 2022 was Bridgeway Capital Management, an estimated $299K sold.

Based on aggregated 13F filings for Q1 2022.